Description
EVISTA (Raloxifene) is a medication prescribed for one or more of the following:
- Treat or prevent osteoporosis in women who have gone through menopause.
- Reduce the risk of invasive breast cancer in women who have gone through menopause and have osteoporosis.
- Reduce the risk of invasive breast cancer in women who have gone through menopause and are at risk of developing invasive breast cancer.
EVISTA is an estrogen agonist and antagonist, meaning it activates or deactivates certain estrogen receptors based on their location in the body. EVISTA is also known as a selective estrogen receptor modulator (SERM).
EVISTA agonizes estrogen receptors in the bone, causing a reduction in the normal breakdown of bone that happens during bone turnover. By decreasing the breakdown of bone, EVISTA increases bone mineral density.
EVISTA helps to prevent invasive breast cancer because it blocks the actions of estrogen in certain breast tissue that may become cancerous when exposed to high levels of estrogen over time.
Fact Table |
Formula |
C28H27NO4S |
License |
EU EMA, US FDA |
Bioavailability |
2% |
Legal status |
RX Only |
Chemical Name |
Raloxifene |
Elimination half-life |
Single dose: 28 hours, Multi-dose: 33 hours |
Dosage (Strength) |
60mg (28 or 84 tablets) |
Pregnancy |
Consult a doctor |
Brands |
Evista |
Protein binding |
Greater than 95% |
PubChem CID |
5035 |
MedlinePlus |
a698007 |
ChEBI |
8772 |
ATC code |
G03XC01 |
DrugBank |
DB00481 |
KEGG |
D08465 |
Routes of administration |
By mouth (tablets) |
Directions
The normal EVISTA dosage is a 60 mg tablet by mouth once daily.
Ingredients
The active ingredient in EVISTA generic is raloxifene.
Cautions
Your doctor should not prescribe EVISTA for the treatment of invasive breast cancer, to reduce the recurrence of breast cancer, or to reduce the risk of noninvasive breast cancer.
Do not use EVISTA if you have a history of clotting disorders, including venous thromboembolism (VTE), pulmonary embolism (PE), or retinal vein thrombosis.
EVISTA should not be used by women who are pregnant, trying to become pregnant or mothers who are nursing. EVISTA should not be used in women who have not undergone menopause.
EVISTA should not be used along with systemic estrogen therapy.
Side Effects
Some of the most common adverse reactions that can occur when taking EVISTA include:
- Arthralgia
- Flu-like symptoms
- Hot flashes
- Leg cramps
- Peripheral edema
- Sweating
Speak with your doctor or pharmacist before starting EVISTA to learn about the full list of side effects that may apply to you.
References
- Evista [package insert]. Indianapolis, IN 46285: Eli Lilly; 2007.
- Mayo Clinic, Osteoporosis, Retrieved April 2020
- Hopkins Medicine, Arthralgia, Retrieved April 2020
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 1516